Prevalence, Incidence and Factors Associated with Diabetic Foot in People with Type 2 Diabetes: Systematic Review with Meta-Analysis
- Авторлар: de Jesus Nascimento de Aquino M.1, de Souza A.C.1, Borges J.W.2, da Silva Negreiros F.1, de Sousa Gonçalves M.3, Martins P.M.2, Moreira T.M.4
-
Мекемелер:
- Endocrinology Outpatient Clinic, Hospital Universitário Walter Cantidio, Rua Pastor Samuel Munguba, 1290, Rodolfo Teófilo, Fortaleza, Ceará, 60430-372, Brazil
- Department of Nursing, Federal University of Piauí, Teresina, Brazil
- Department of Nursing, Centro Universitário UNINTA, Sobral, Brazil
- Clinical Care in Nursing and Health Gradutate Program, Universidade Estadual do Ceará, Fortaleza, Brazil
- Шығарылым: Том 20, № 1 (2024)
- Бөлім: Medicine
- URL: https://snv63.ru/1573-3998/article/view/642947
- DOI: https://doi.org/10.2174/1573399819666230407093450
- ID: 642947
Дәйексөз келтіру
Толық мәтін
Аннотация
Background:Diabetic Foot is a severe chronic complication of diabetes and an important factor in the morbidity of diabetic people, resulting in high health costs and increased risk of death.
Objective:To analyze the incidence, prevalence, and risk factors associated with diabetic foot in people with type 2 Diabetes Mellitus.
Method:Systematic literature review. Searches in MedLine via PubMed, LILACS, Web of Science, Scopus CINAHL, and Cochrane Library databases were performed. Inclusion of 52 studies. The R program, Metan packages, was used to calculate the meta-analysis. Given the heterogeneity of studies, the random effect was used to calculate the meta-analysis of risk factors.
Results:The meta-analysis showed that the prevalence of diabetic foot was 14% in a hospital setting and 5% in a community setting. The overall prevalence and incidence were 9% and 4%, respectively. Significant risk factors included time of DM (odds ratio [OR] =1.46, confidence interval [CI], 0.36-2.57, P = 0.009), smoking (OR = 1.46, CI, 1.16 -1.85, P< .001), glycated hemoglobin (OR = 0.96, CI, 0.50; 1.42, P< .001), peripheral arterial disease (OR = 3.38, CI, 2.07; 5.53, P < .001) and peripheral neuropathy (OR = 5.88, CI, 2.39-14.45, P<.001).
Conclusion:Multidisciplinary monitoring, educational strategies, periodic foot examination for alterations, and early identification of risk factors are essential to prevent ulceration and reduce the disease burden.
Негізгі сөздер
Авторлар туралы
Maria de Jesus Nascimento de Aquino
Endocrinology Outpatient Clinic, Hospital Universitário Walter Cantidio, Rua Pastor Samuel Munguba, 1290, RodolfoTeófilo, Fortaleza, Ceará, 60430-372, Brazil
Email: info@benthamscience.net
Ana de Souza
Endocrinology Outpatient Clinic, Hospital Universitário Walter Cantidio, Rua Pastor Samuel Munguba, 1290, RodolfoTeófilo, Fortaleza, Ceará, 60430-372, Brazil
Хат алмасуға жауапты Автор.
Email: info@benthamscience.net
José Borges
Department of Nursing, Federal University of Piauí, Teresina, Brazil
Email: info@benthamscience.net
Francisca da Silva Negreiros
Endocrinology Outpatient Clinic, Hospital Universitário Walter Cantidio, Rua Pastor Samuel Munguba, 1290, RodolfoTeófilo, Fortaleza, Ceará, 60430-372, Brazil
Email: info@benthamscience.net
Marilia de Sousa Gonçalves
Department of Nursing, Centro Universitário UNINTA, Sobral, Brazil
Email: info@benthamscience.net
Polyanna Martins
Department of Nursing, Federal University of Piauí, Teresina, Brazil
Email: info@benthamscience.net
Thereza Moreira
Clinical Care in Nursing and Health GradutateProgram, Universidade Estadual do Ceará, Fortaleza, Brazil
Email: info@benthamscience.net
Қосымша файлдар
